PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|March 2, 2014
The Qualicaps HICAPSEAL S-100
The Qualicaps HICAPSEAL S-100
Advertisement
Qualicaps HICAPSEAL® S-100 is a capsule sealing machine that ensures a leak-proof, hermetic seal of cap to body. Ideal for sealing gelatin and hypromellose capsules, HICAPSEAL equipment is commercially-accepted and proven technology. The S-100 places double band seal, which ensures air bubbles or unevenness in the first band, will be eliminated by the second application. The S-100 can seal 100,000 capsules per hour.
Qualicaps, Whitsett, NC
•
INTERPHEX Booth # 3516
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement